Melanóma: nyitott vizsgálatok itt: Svájc
14 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
- Where
- Basel, Bellinzona, Bern, Fribourg, Geneva, Lausanne, Münsterlingen, Sankt Gallen, Zurich
- Age
- 18 év and over
- People
- 108
- Run by
- Swiss Cancer Institute
See details and how to joinNCT07574047Regiszter frissítve: 2026-10-27
2/3. fázisToborozTrial-stage medicine
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Chur, Zurich
- Age
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301EU 2024-512659-19-00Regiszter frissítve: 2026-10-06
3. fázisToborozTrial-stage medicine
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Lausanne
- Age
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904EU 2022-503140-41-00Regiszter frissítve: 2026-09-24
No phaseToborzás még nem indultResearch participation
A Comparative Usability Study of Two Total Body Skin Imaging Systems
- Where
- Basel
- Age
- 18 év and over
- People
- 60
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07740642Regiszter frissítve: 2026-08-03
1. fázisToborozTrial-stage medicine
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
- Where
- Lausanne
- Age
- 18 év and over
- People
- 9
- Run by
- Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT06889766Regiszter frissítve: 2026-05-15
3. fázisToborozTrial-stage medicine
Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Basel, Zurich
- Age
- 18 év and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190EU 2025-522387-32-00Regiszter frissítve: 2026-05-06
3. fázisToborozTrial-stage medicine
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
- Where
- Bern, Winterthur, Zurich
- Age
- 18 év and over
- People
- 180 worldwide
- Run by
- ETOP IBCSG Partners Foundation
See details and how to joinNCT05522660Regiszter frissítve: 2026-04-27
2. fázisToborzás még nem indultResearch participation
Screening for Brain Metastases
- Where
- Zurich
- Age
- 18 év and over
- People
- 180
- Run by
- University of Zurich
See details and how to joinNCT07492121Regiszter frissítve: 2026-03-25
3. fázisToborozTrial-stage medicine
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Where
- Sankt Gallen, Zurich
- Age
- 18 év and over
- People
- 540 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT05549297EU 2022-502732-39-00Regiszter frissítve: 2026-02-25
3. fázisToborozTrial-stage medicine
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Zurich
- Age
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314Regiszter frissítve: 2026-02-25
3. fázisToborozTrial-stage medicine
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Where
- Basel, Bellinzona, Bern, Geneva, Sankt Gallen, Zurich
- Age
- 18 év and over
- People
- 186 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT03567889EU 2023-507119-36-00Regiszter frissítve: 2025-12-17
No phaseToborozTrial-stage medicine
Skin Cancer and Hyperthermia and Radiotherapy
- Where
- Aarau, Bern, Lucerne, Winterthur
- Age
- 65 év and over
- People
- 100
- Run by
- Kantonsspital Winterthur KSW
See details and how to joinNCT06384053Regiszter frissítve: 2025-06-15
No phaseToborozResearch participation
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Bern, Zurich
- Age
- 18 év and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767Regiszter frissítve: 2024-08-26
No phaseToborozResearch participation
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
- Where
- Aarau, Bellinzona, Bern, Chur, Lausanne, Lucerne, Winterthur, Zurich
- Age
- 18 év and over
- People
- 750 worldwide
- Run by
- Pierre Fabre Pharma GmbH
See details and how to joinNCT04045691Regiszter frissítve: 2021-01-19
Minden vizsgálat (Melanóma) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.